RHOA and hyperlipidemia: In summary, the present study demonstrated that GLXB is able to relieve I/R-induced myocardial injury for the hyperlipidemia subject with an efficiency similar to simvastatin, a potential that is likely related with regulating energy metabolism involving RhoA/ROCK signaling pathway (Figure 11).